MUMBAI, India, April 10, 2023 /PRNewswire/ — Calibre Chemicals, a leading nutrition, pharmaceuticals, and personal care specialty chemicals company, announced today that it has reached an agreement with the proprietors of Bengaluru-based Tina Life Sciences, to acquire Tina's laboratory and product development business with immediate effect.
With this acquisition, Calibre has taken a step forward to further enhance its R&D capabilities, especially in the field of complex organic chemistry. Calibre will enhance the pace of new product development and the breadth of its Custom Development and Manufacturing (CDMO) Service offerings.
Dr. Pintoo Ganguly, an accomplished chemist having diverse experience in developing products and processes in the Indian chemical industry, would lead Caibre's R&D activities.
“We are excited to accredit broader and newer R&D capabilities and welcome Dr. Ganguly and his team to Calibre family,“ said Mr. Deepak Chander, CEO of Calibre Chemicals. “Our collective expertise and knowledge of organic synthesis, electrochemistry, process development, and manufacturing excellence, will enable us in serving our valued customers better.”
Calibre R&D centre is based in Bengaluru, India, and another laboratory-cum-pilot-plant at our manufacturing facility in Sarigam, Gujarat.
(Disclaimer: The above press release comes to you under an arrangement with PRNewswire India and this publication takes no editorial responsibility for the same)
More Stories
Qlik’s Accelerating Growth Attracts Significant Investment from Thoma Bravo and ADIA
Golden Eagles Golf Championship Returns for its 8th Edition with Unmatched Glamour, Golf, and Glory with Kapil Dev
Weekend Escapes from Delhi: Uncover Timeless Heritage, Royal Splendor and Scenic Charms